Literature DB >> 21705225

Convolutamines I and J, antitrypanosomal alkaloids from the bryozoan Amathia tortusa.

Rohan A Davis1, Melissa Sykes, Vicky M Avery, David Camp, Ronald J Quinn.   

Abstract

Mass-directed isolation of the CH(2)Cl(2)/CH(3)OH extract from the marine bryozoan Amathia tortusa resulted in the purification of two new brominated alkaloids, convolutamines I (1) and J (2). The structures of 1 and 2 were determined following spectroscopic data analysis. Both compounds were isolated during a drug discovery program aimed at identifying new antitrypanosomal leads from a prefractionated natural product library. Compounds 1 and 2 were shown to be active toward the parasite Trypanosoma brucei brucei with IC(50) values of 1.1 and 13.7 μM, respectively. Preliminary toxicity profiling was also performed on both 1 and 2 using the human embryonic kidney cell line, HEK293. Compound 1 was shown to exhibit cytotoxicity against HEK293 with an IC(50) of 22.0 μM whilst 2 was inactive at 41.0 μM.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705225     DOI: 10.1016/j.bmc.2011.06.006

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

Review 1.  Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery.

Authors:  Xiang Rong Tian; Hai Feng Tang; Xiao Lin Tian; Jia Jun Hu; Li Li Huang; Kirk R Gustafson
Journal:  Future Med Chem       Date:  2018-05-23       Impact factor: 3.808

2.  N¹,N¹-Dimethyl-N³-(3-(trifluoromethyl)phenethyl)propane-1,3-diamine, a new lead for the treatment of human African trypanosomiasis.

Authors:  Ngoc B Pham; Sophie Deydier; Mehdi Labaied; Séverine Monnerat; Kenneth Stuart; Ronald J Quinn
Journal:  Eur J Med Chem       Date:  2014-01-09       Impact factor: 6.514

Review 3.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

Review 4.  Trypanocidal activity of marine natural products.

Authors:  Amy J Jones; Tanja Grkovic; Melissa L Sykes; Vicky M Avery
Journal:  Mar Drugs       Date:  2013-10-22       Impact factor: 5.118

5.  5-Alkylresorcinol Derivatives from the Bryozoan Schizomavella mamillata: Isolation, Synthesis, and Antioxidant Activity.

Authors:  María J Ortega; Juan J Pantoja; Carolina de Los Reyes; Eva Zubía
Journal:  Mar Drugs       Date:  2017-11-02       Impact factor: 5.118

Review 6.  Current Screening Methodologies in Drug Discovery for Selected Human Diseases.

Authors:  Olga Maria Lage; María C Ramos; Rita Calisto; Eduarda Almeida; Vitor Vasconcelos; Francisca Vicente
Journal:  Mar Drugs       Date:  2018-08-14       Impact factor: 5.118

7.  Chemoinformatic analysis as a tool for prioritization of trypanocidal marine derived lead compounds.

Authors:  Yunjiang Feng; Marc Campitelli; Rohan A Davis; Ronald J Quinn
Journal:  Mar Drugs       Date:  2014-03-04       Impact factor: 5.118

8.  Neopetrocyclamines A and B, polycyclic diamine alkaloids from the sponge Neopetrosia cf exigua.

Authors:  Zhibin Liang; Florian J Sulzmaier; Wesley Y Yoshida; Michelle Kelly; Joe W Ramos; Philip G Williams
Journal:  J Nat Prod       Date:  2015-01-13       Impact factor: 4.803

9.  Screening a Natural Product-Based Library against Kinetoplastid Parasites.

Authors:  Bilal Zulfiqar; Amy J Jones; Melissa L Sykes; Todd B Shelper; Rohan A Davis; Vicky M Avery
Journal:  Molecules       Date:  2017-10-12       Impact factor: 4.411

Review 10.  The Phylum Bryozoa: From Biology to Biomedical Potential.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Leandro M Vieira; Robert Kiss; Marianna Carbone; Willem A L van Otterlo; Nicole B Lopanik; Andrea Waeschenbach
Journal:  Mar Drugs       Date:  2020-04-09       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.